» Articles » PMID: 38202777

Identification of Potential Plant-Derived Pancreatic Beta-Cell-Directed Agents Using New Custom-Designed Screening Method: As an Example

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2024 Jan 11
PMID 38202777
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Folk medicines are attractive therapeutic agents for treating type 2 diabetes mellitus (T2DM). Most plant extracts that have been suggested to restore β-cells function were tested in vivo. Some only have been tested in vitro to determine whether they have a direct effect on β-cells islets of Langerhans. Currently, there are no defined criteria for screening of β-cell-directed plant-based remedies as potential antidiabetic agents.

Summary: In this review, we have identified certain criteria/characteristics that can be used to generate a "screening portfolio" to identify plant extracts as potential β-cell-directed agents for the treatment of T2DM. To validate our screening method, we studied the potential therapeutic efficacy of a (GS) extract using the screening criteria detailed in the review. Six criteria have been identified and validated using OSA, a GS extract. By using this screening method, we show that OSA fulfilled most of the criteria identified for an effective β-cell-directed antidiabetic therapy, being an effective insulin-releasing agent at nontoxic concentrations; maintaining β-cell insulin content by stimulating a concomitant increase in insulin gene transcription; maintaining β-cell mass by protecting against apoptosis; and being effective at maintaining normoglycemia in vivo in a mouse model and a human cohort with T2DM.

Key Messages: The present review has highlighted the importance of having a screening portfolio for plant extracts that have potential antidiabetic effects in the treatment of T2DM. We propose that this screening method should be adopted for future studies to identify new β-cell-directed antidiabetic plant derived agents.

Citing Articles

Notoginsenoside R1, a metabolite from Panax notoginseng (Burkill) F.H.Chen, stimulates insulin secretion through activation of phosphatidylinositol 3-kinase (PI3K)/Akt pathway.

Al-Romaiyan A, Barakat A, Marafie S, Masocha W Front Pharmacol. 2024; 15:1478917.

PMID: 39399466 PMC: 11466869. DOI: 10.3389/fphar.2024.1478917.

References
1.
Schulz I . Permeabilizing cells: some methods and applications for the study of intracellular processes. Methods Enzymol. 1990; 192:280-300. DOI: 10.1016/0076-6879(90)92077-q. View

2.
Al-Romaiyan A, Huang G, Jones P, Persaud S . Commiphora myrrha stimulates insulin secretion from mouse and human islets of Langerhans. J Ethnopharmacol. 2020; 264:113075. DOI: 10.1016/j.jep.2020.113075. View

3.
Frayling T . Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet. 2007; 8(9):657-62. DOI: 10.1038/nrg2178. View

4.
Gaytan Martinez L, Sanchez-Ruiz L, Zuniga L, Gonzalez-Ortiz M, Martinez-Abundis E . Effect of Administration on Glycemic Control, Insulin Secretion, and Insulin Sensitivity in Patients with Impaired Glucose Tolerance. J Med Food. 2020; 24(1):28-32. DOI: 10.1089/jmf.2020.0024. View

5.
Poitout V, Robertson R . Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev. 2007; 29(3):351-66. PMC: 2528858. DOI: 10.1210/er.2007-0023. View